Evidence map›Paper›PMID 30881954›Full record

ArticleFrontiers in bioengineering and biotechnology2019

Follistatin Effects in Migration, Vascularization, and Osteogenesis

Shorouk Fahmy-Garcia, Eric Farrell, Janneke Witte-Bouma, Iris Robbesom-van den Berge, Melva Suarez, Didem Mumcuoglu, Heike Walles, Sebastiaan G J M Kluijtmans, Bram C J van der Eerden, Gerjo J V M van Osch and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04206618 (The Role of Myokines in Postmenopausal Osteoporosis), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04206618 completednot on this map

The Role of Myokines in Postmenopausal Osteoporosis

TypeobservationalSponsor424 General Military HospitalRan2019 to 2020Enrolled220ConditionsOsteoporosis, PostmenopausalArmsTeriparatide, Denosumab
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. A 1, 4-benzoquinone derivative isolated fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Shorouk Fahmy-GarciaDepartment of Orthopedics, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Eric FarrellDepartment of Oral and Maxillofacial Surgery, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Janneke Witte-BoumaDepartment of Oral and Maxillofacial Surgery, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Iris Robbesom-van den BergeDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Melva SuarezInstitute of Tissue Engineering and Regenerative Medicine, Julius-Maximillians University Würzburg, Würzburg, Germany.
Didem MumcuogluDepartment of Orthopedics, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Heike WallesInstitute of Tissue Engineering and Regenerative Medicine, Julius-Maximillians University Würzburg, Würzburg, Germany.
Sebastiaan G J M KluijtmansFujifilm Manufacturing Europe B.V., Tilburg, Netherlands.
Bram C J van der EerdenDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Gerjo J V M van OschDepartment of Orthopedics, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Johannes P T M van LeeuwenDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Marjolein van DrielDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Erasmus MC · NLFujifilm (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of biomaterials and signaling molecules to induce bone formation is a promising approach in the field of bone tissue engineering. Follistatin (FST) is a glycoprotein able to bind irreversibly to activin A, a protein that has been reported to inhibit bone formation. We investigated the effect of FST in critical processes for bone repair, such as cell recruitment, osteogenesis and vascularization, and ultimately its use for bone tissue engineering.

Indexed as

bone tissue engineeringfollistatin 288 (FST288)follistatin 315 (FST315)injectable in situ gelling slow release systemmigrationosteogenesisregenerative medicinevascularization

Identifiers

PMID30881954
PMCPMC6405513
OpenAlexW2918040417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.